Skip to main content
All lobbying filings

Tenagrity Solutions, LLC

Tenagrity Solutions, LLC filed a Q2 report for Soter Bio Inc. on July 20, 2026.

Lobbying for Soter Bio Inc. · specialized biologics consulting firm

As filed: TENAGRITY SOLUTIONS, LLC for SOTER BIO INC.

All filings by Tenagrity Solutions, LLC · Everything Soter Bio Inc. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Texas

Official filing document

 Lobbyists on this filing 1
  • JENNY CAROLINE DEBERRY
    Previously held: Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity, critical for disaster preparedness

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem